Alfuxyle T 5 Tablet contains Alfuzosin 10mg + Tadalafil 5mg, a dual-action therapy designed for effective management of BPH and erectile dysfunction. Alfuzosin relaxes prostate and bladder muscles, improving urinary flow, while Tadalafil enhances blood circulation to support sexual function.
This combination is preferred by urologists due to its potent dual effect, safety, and tolerability, providing patients with reliable symptom relief and improved quality of life. Users experience enhanced urinary comfort, better sexual performance, and overall urological health.
For franchise partners, Alfuxyle T 5 Tablet is a high-demand product in the urology care segment, offering strong repeat prescriptions and steady market potential. Its dual-therapy profile makes it a profitable addition to specialty portfolios, boosting sales and brand credibility.
With the rising prevalence of BPH and erectile dysfunction, Alfuxyle T 5 Tablet ensures sustainable business growth, helping partners strengthen their presence in the urology care segment.